The Use of 23-Valent Pneumococcal Polysaccharide Vaccine in Patients with Rheumatoid Arthritis

The Use of 23-Valent Pneumococcal Polysaccharide Vaccine in Patients with Rheumatoid Arthritis

Objective: to study the clinical efficacy, immunogenicity, and safety of a 23-valent pneumococcal vaccine in patients with rheumatoid arthritis (RA).Subjects and methods. The investigation enrolled 102 patients (78 women and 24 men, aged 23 – 70 years), including 72 patients with RA and 30 people wi...

Full description

Bibliographic Details
Main Authors: M. S. Naumtseva, B. S. Belov, G. M. Tarasova, D. E. Karateev, E. L. Luchikhina, Yu. V. Muravyev, E. N. Aleksandrova, A. A. Novikov
Format: Article
Language:Russian
Published: Numikom LLC 2015-08-01
Series:Эпидемиология и вакцинопрофилактика
Subjects:
ревматоидный артрит
аутоиммунные заболевания
коморбидные инфекции
коморбидность
пневмония
бронхиты
пневмококковая вакцина
вакцинация
иммуногенность
эффективность
переносимость
Online Access:https://www.epidemvac.ru/jour/article/view/384

Internet

https://www.epidemvac.ru/jour/article/view/384

Similar Items